Abstract: A system for introducing an intraluminal endoprosthesis (30), preferably a stent, into a body cavity. The system consists of the intraluminal endoprosthesis (30) and a catheter with a balloon (10), the balloon (10) having at least one wing (12) in an undilated condition. The system has at least one active pharmaceutical substance (20) arranged at least partially beneath the at least one wing (12) of the balloon (10) in the undilated condition. The intraluminal endoprosthesis (30) is fixedly arranged on the folded balloon (10) such that the endoprosthesis surrounds the balloon at least partially and protects the at least one active pharmaceutical substance (20) from being washed out and rubbed off. Further disclosed is a method for manufacturing such a system.
Type:
Application
Filed:
February 13, 2009
Publication date:
March 25, 2010
Applicant:
Biotronik VI Patent AG
Inventors:
Bjoern Klocke, Matthias Fringes, Claus Martini, Stefan Mueller
Abstract: Stent, as well as a method and device for fabricating the stent, wherein the stent has a tubular lattice structure comprising individual struts and at least one strut of which at least one longitudinal section runs with at least one directional component in the radial circumferential direction of the stent, wherein the surface of the longitudinal section facing the outside of the stent is curved only about the longitudinal axis of the stent. According to the invention, the surface of longitudinal section of the strut, which surface faces the inside of the stent, has such a curvature that the strut cross section is fluidically optimized.
Abstract: A method of treating a patient includes the medical use of one or more of the elements from the group yttrium, neodymium and zirconium, pharmaceutical formulations which contain said elements and implants which are at least region-wise made up of such formulations. It has been found inter alia that a formulation containing one or more of the elements has an action of inhibiting the proliferation of human smooth muscle cells.
Type:
Application
Filed:
October 8, 2009
Publication date:
February 11, 2010
Applicant:
BIOTRONIK VI PATENT AG
Inventors:
Claus Harder, Bernd Heublein, Eva Heublein, Nora Heublein, Christoph Heublein
Abstract: An implantable sensor for measuring fluidic parameters with a surface acoustic wave transponder for detecting vasomotor quantities and one retaining stent attached to each of two opposite ends of the surface acoustic wave transponder.
Abstract: The invention relates to an implant having a base body consisting completely or partially of a biocorrodible metallic material, the material being such that it decomposes in an aqueous environment to yield an alkaline product and the base body has a coating comprising or containing a hydrogel, characterized in that the hydrogel has a reduced swelling capacity at an elevated pH.
Abstract: An insertion system (100) for a medical device (10), which is situated in an outer sheath (20) upon insertion, the outer sheath (20) at least regionally encompassing an inner shaft. The outer sheath (20) at least regionally has, at least on its inner side (29) facing toward the medical device (10), a structure (22, 32) which is complementary with an external-peripheral segmented structure (12) of the medical device (10) like a bolt-nut connection.
Abstract: An implant system comprising a functional implant (5, 6) that fulfills a medical function, particularly a bone implant, which is formed at least in part of a metal material that can be degraded by the body (2) of the implant wearer, as well as a control device (7) for controlling the degradation behavior of the functional implant (5, 6). The control device (7) has a counter-electrode (10) to the functional implant (5, 6), and a voltage source (8) for making available a polarization voltage (?U) between functional implant (5, 6, 15) and counter-electrode (10), to control the degradation behavior of the functional implant (5, 6).
Type:
Application
Filed:
July 8, 2009
Publication date:
January 14, 2010
Applicant:
BIOTRONIK VI PATENT AG
Inventors:
Bodo Gerold, Bjoern Klocke, Matthias Fringes
Abstract: A stent comprising stent struts (1) of a biodegradable polymer material, drug depots (4) having at least one drug in the stent struts (1), at least one drug that treats the consequences of degradation of the stent struts (1) and sheathing of the drug depots (4) that varies over time, such that the drug delivery from the drug from the drug depots (4) is timed to coordinate with the mass degradation of the biodegradable polymer material of the stent struts (1).
Abstract: A device for the minimally invasive insertion into a lumen of a hollow organ comprises a hose-shaped wall (3) with a multiplicity of piezoelectric fibers (4) embedded therein.
Abstract: An implant for a human or animal body, comprising a surface having reduced thrombogenic properties, whose surface has a wetting angle of ?, where ??80°. Also disclosed is a method for producing an implant and the use an implant to reduce the dose or concentration in administration of a concomitant systemic medication with one or more anticoagulant active ingredients before, during or after implantation of the implant in a human or animal body.
Abstract: A delivery system having a release mechanism (70) for releasing an object (12), in particular, a supporting body, which is carried by the catheter (20), whereby the catheter (20) has at least one outer shaft (50) which is relatively displaceable toward the object (12) to release the object (12). The catheter (20) has a winding device (100) on its proximal end (24) which winds up a proximal section (52) of the outer shaft (50) to create a relative displacement of the outer shaft (50).
Type:
Application
Filed:
April 27, 2009
Publication date:
October 29, 2009
Applicant:
Biotronik VI Patent AG
Inventors:
Amir Fargahi, Raimund Moehl, Vesna Colic, Patrice Bachmann
Abstract: A biodegradable metal stent having delayed degradation after implantation, the stent comprising a stent material coated with at least one wax material, Also provided is a method for manufacturing and use of such a stent.
Abstract: A stent fixation system 3 for fixation of a stent, comprising two retaining areas 10 which are connected by a connecting area 12 to form a fixation tubing. The retaining areas 10 provide a retaining structure which is designed to hold at least one stent strut 2 of the stent in the undilated state, such that the stent struts 2 are no longer in one of the retaining areas 10, at least in the dilated state of the stent.
Type:
Application
Filed:
April 27, 2009
Publication date:
October 29, 2009
Applicant:
BIOTRONIK VI PATENT AG
Inventors:
Bettina Surber, Daniel Wintsch, Tommy Conzelmann, Nils Goetzen, Bodo Gerold, Alexander Borck
Abstract: A medical supporting implant, in particular a stent, comprises a tubular base body which is made up of bendable struts (2), such that at node points (4) of at least two struts (2), the bendable struts (2) form an acute angle (W) to one another which angle becomes larger on dilatation of the implant with plastic deformation of the struts (2) at the node point (4). At least a portion of the struts (2) between the plastic deformation areas (4) is provided with a telescoping ratchet mechanism (R) for irreversible lengthening of the respective struts (2) on dilatation.
Abstract: A catheter guidewire (1), preferably for cardiovascular procedures, having a distal end (2) and a proximal end (3) and a one-piece core (10) extending essentially from the distal end to the proximal end. The one-piece core has twisted fibers, preferably glass fibers, which are embedded in the basic material of the core. Also disclosed is a method for manufacturing a catheter guidewire.
Abstract: A catheter (10) having an internal tube (13) and an external tube (14) which at least sectionally encloses the internal tube (13). The external tube (14) is connected to a balloon (16) having an endoprosthesis section (18) which positions an intraluminal endoprosthesis (20). The catheter (10) has stiffening means (31, 33, 34, 35) located in the area of at least one end of the endoprosthesis section (18) in its longitudinal direction on the internal tube (13). Also disclosed is a system comprising an intraluminal endoprosthesis (20) and a catheter (10) used for introducing an intraluminal endoprosthesis (20), preferably a stent, into a body cavity.
Abstract: A catheter having a balloon (10) which has at least one wing (12) in the undilated state, the balloon having at least one fold element (11, 11?, 31, 32, 41, 42) running essentially in the longitudinal direction for each wing (12), such that in folding the balloon (10), the fold element is arranged in an area of the wing (12) with a minimum in the bending radius, said area running in the longitudinal direction. Also disclosed is a system for introducing an intraluminal endoprosthesis, preferably a stent, into a body cavity consisting of an intraluminal endoprosthesis and a catheter having the balloon as described. Further, disclosed are methods of producing such a catheter and such a system.
Abstract: An implant having a base body comprising entirely or in part a biocorrodible iron alloy wherein the base body of the implant comprises at least one of the following: (i) a biocorrodible iron alloy of formula (1): Fe—P where the amount of P in the alloy is from 0.
Type:
Application
Filed:
February 5, 2009
Publication date:
August 6, 2009
Applicant:
BIOTRONIK VI PATENT AG
Inventors:
Heinz Mueller, Joerg Loeffler, Peter Uggowitzer
Abstract: An implant having a base body consisting entirely or in part of a biocorrodible metallic material wherein at least the parts of the base body made of the biocorrodible metallic material are covered with a corrosion-inhibiting coating. The coating comprises a primer layer of a first biodegradable polymer material comprising a poly(D,L-lactide) (PDLLA) with a degree of polymerization in the range of 5 to 20 and a protective layer of a second biodegradable polymer material comprising a diblock copolymer (PEG/PLGA) of polyethylene glycol (PEG) and poly(D,L-lactide-co-glycolide) (PLGA) applied to the primer layer.
Abstract: A multi-membrane balloon (10) for a catheter having an at least double membrane sleeve (20, 40) comprising at least one fillable and emptiable expansion space (46) between a proximal end (12) and a distal end (14), wherein a stiff supporting element (60) surrounds the at least double membrane sleeve (20, 40) and the outer membrane sleeve (20) surrounds one or more inner membrane sleeves (40). The supporting element (60) at least partially takes hold with the outer membrane sleeve (20).